1. The subject of this order is the successive supply of medicines to the Oncology Center of the Institute Maria Skłodowska-Curie Branch in Gliwice ,.

2. The description of the subject of the contract and the terms of the contract are contained in the forms:

a) Assortment and price specification - attachments No. 2.1-2.3 to the ToR

b) Model contract - Annex 4 to the ToR

3. If the medication in the international name is on the reimbursement letter, then the offered drug must be on it and its price must be equal to or lower than the funding limits.

4. The Contracting Authority does not envisage concluding a framework agreement, establishing a dynamic purchasing system, electronic auction and supplementary orders.

5. Detailed information on these proceedings is contained in the ToR.

1. The description of the subject of the contract and the terms of the contract are contained in the forms:

a) Assortment and price specification - attachments No. 2.1 to SIWZ;

b) Model contract - Annex 4 to the ToR.

2. Medicines that are the subject of this contract have established quality standards.

These standards have been established for each drug during its registration and are the same within the chemical substances included in their composition. Drugs for their use do not require any distinctive elements within individual substances. In addition, every drug that is traded on the territory of the Republic of Poland must be registered.

3. The medicaments being the subject of the order must be allowed to be used in Poland in accordance with the provisions of the Pharmaceutical Law Act of September 6, 2001 (Journal of Laws of 2017, item 2211, as amended) - the contractor must have all the documents required by law admitting to trading on the territory of the Republic of Poland for the offered drug and presenting them at the request of the Ordering Party.

4. The Employer allows the possibility of changing the form of oral forms with the exception of soluble forms and the possibility of changing the ampoule into a vial.

5. Preparations with the same chemical name, but with different doses, must be offered from one producer, so that in practice it is possible to combine doses.

6. In the tasks in which the dose is not specified, the orderer reserves the right to place orders for all doses produced by a given manufacturer.

7. If the medication in the international name is on the reimbursement letter, then the offered medicine must be on it and its price must be equal to or lower than the funding limits.

8. Deadline for completing the subject of the order: successively until December 31, 2020 counting from the day of concluding the contract or until the financial limit of the Awarding Entity for the performance of this contract specified in § 3 para. 1 of the contract constituting an attachment to the ToR.

1. The description of the subject of the contract and the terms of the contract are contained in the forms:

a) Assortment and price specification - attachments No. 2.2 to the ToR;

b) Model contract - Annex 4 to the ToR.

2. Medicines that are the subject of this contract have established quality standards.

These standards have been established for each drug during its registration and are the same within the chemical substances included in their composition. Drugs for their use do not require any distinctive elements within individual substances. In addition, every drug that is traded on the territory of the Republic of Poland must be registered.

3. The medicaments being the subject of the order must be allowed to be used in Poland in accordance with the provisions of the Pharmaceutical Law Act of September 6, 2001 (Journal of Laws of 2017, item 2211, as amended) - the contractor must have all the documents required by law admitting to trading on the territory of the Republic of Poland for the offered drug and presenting them at the request of the Ordering Party.

4. The Employer allows the possibility of changing the form of oral forms with the exception of soluble forms and the possibility of changing the ampoule into a vial.

5. Preparations with the same chemical name, but with different doses, must be offered from one producer, so that in practice it is possible to combine doses.

6. In the tasks in which the dose is not specified, the orderer reserves the right to place orders for all doses produced by a given manufacturer.

7. If the medication in the international name is on the reimbursement letter, then the offered medicine must be on it and its price must be equal to or lower than the funding limits.

8. Deadline for completing the subject of the order: successively until 31.12.2020 counting from the date of conclusion of the contract or until the financial limit of the Awarding Entity for the performance of this contract specified in § 3 para. 1 of the contract constituting an attachment to the ToR.

1. The description of the subject of the contract and the terms of the contract are contained in the forms:

a) Assortment and price specification - attachments No. 2.3 to the ToR;

b) Model contract - Annex 4 to the ToR.

2. Medicines that are the subject of this contract have established quality standards.

These standards have been established for each drug during its registration and are the same within the chemical substances included in their composition. Drugs for their use do not require any distinctive elements within individual substances. In addition, every drug that is traded on the territory of the Republic of Poland must be registered.

3. The medicaments being the subject of the order must be allowed to be used in Poland in accordance with the provisions of the Pharmaceutical Law Act of September 6, 2001 (Journal of Laws of 2017, item 2211, as amended) - the contractor must have all the documents required by law admitting to trading on the territory of the Republic of Poland for the offered drug and presenting them at the request of the Ordering Party.

4. The Employer allows the possibility of changing the form of oral forms with the exception of soluble forms and the possibility of changing the ampoule into a vial.

5. Preparations with the same chemical name, but with different doses, must be offered from one producer, so that in practice it is possible to combine doses.

6. In the tasks in which the dose is not specified, the orderer reserves the right to place orders for all doses produced by a given manufacturer.

7. If the medication in the international name is on the reimbursement letter, then the offered medicine must be on it and its price must be equal to or lower than the funding limits.

8. Deadline for completing the subject of the order: successively until December 31, 2020 counting from the day of concluding the contract or until the financial limit of the Awarding Entity for the performance of this contract specified in § 3 para. 1 of the contract constituting an attachment to the ToR.